Skyrizi
NDC 0074-1065, Risankizumab-rzaa, kit, from AbbVie Inc..
- Product NDC
- 0074-1065
- Status
- Listed
- Labeler
- AbbVie Inc.
- Dosage form
- KIT
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761105
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0074-1065-01 | 00074106501 | 1 KIT in 1 CARTON (0074-1065-01) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01) |
| 0074-1065-02 | 00074106502 | 1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7148c8eb-b39e-e20a-6494-a6df82392858NADAC price for package 00074106501
GET /v1/drugs/nadac/00074106501
Use it
Look up 0074-1065 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1065 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0074-1065. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.